- Latest available (Revised)
- Point in Time (11/02/2022)
- Original (As made)
Version Superseded: 28/02/2022
Point in time view as at 11/02/2022. This version of this provision has been superseded.
You are viewing this legislation item as it stood at a particular point in time. A later version of this or provision, including subsequent changes and effects, supersedes this version.
Note the term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section.
There are currently no known outstanding effects for the The Health Protection (Coronavirus, International Travel and Operator Liability) (England) Regulations 2021, Section 3A.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
3A.—(1) For the purposes of this Part—
(a)a child is to be treated as making a declaration on a Passenger Locator Form, and providing any proof required, if that declaration is made, and the proof provided, by a person who is travelling with and has responsibility for that child;
(b)a person is not treated as having been in a country or territory if that person would not be treated as having departed from or transited through that country or territory by virtue of regulation 2(3);
[F2(c)a reference to a country does not include a reference to the overseas territories and dependencies of that country unless otherwise stated.]
(2) In this Part—
“authorised vaccine” means a medicinal product for vaccination against coronavirus—
in relation to doses received in the United Kingdom, authorised—
for supply in the United Kingdom in accordance with a marketing authorisation, or
by the licensing authority on a temporary basis under regulation 174 of the Human Medicines Regulations 2012,
in relation to doses received in a relevant country listed in the table in paragraph (3), authorised for supply in that relevant country following evaluation by the regulator for the relevant country,
“clinical trial” has the meaning given in regulation 2(1) of the Medicines for Human Use (Clinical Trials) Regulations 2004;
F8...
F9...
“the licensing authority” has the meaning given in regulation 6(2) (the licensing authority and the Ministers) of the Human Medicines Regulations 2012;
“marketing authorisation”—
in relation to a vaccine authorised for supply in the United Kingdom or in a member State, has the meaning given in regulation 8(1) (general interpretation) of the Human Medicines Regulations 2012,
in relation to a vaccine authorised for supply in a relevant country listed in the table in paragraph (3) other than a member State, means a marketing authorisation granted by the relevant regulator for the country;
“medicinal product” has the meaning given in regulation 2 (medicinal products) of the Human Medicines Regulations 2012;
“NHS COVID pass” means the COVID-19 records [F10available] on the NHS smartphone app developed and operated by the Secretary of State, through the website at NHS.uk or [F11in] a COVID-19 post-vaccination letter obtained from the NHS;
“NHS” means the health service continued under section 1(1) of the National Health Service Act 2006;
“NHS Scotland” means the health service continued under section 1(1) of the National Health Service (Scotland) Act 1978;
“NHS Wales” means the health service continued under section 1(1) of the National Health Service (Wales) Act 2006;
[F12North American Certificate” means, in relation to a State listed in the table in paragraph (2B), the certificate identified in the corresponding row of the second column of that table;]
[F13“Regulation (EU) 2021/953” means Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic;]
“relevant country” means a country or territory listed in the first column of the table in paragraph (3) or a country or territory listed in paragraph (4);
“regulator”, in relation to a relevant country listed in the table in paragraph (3), means the regulator identified in the corresponding row of the second column of the table in that paragraph, and a reference to a regulator in that table is a reference to the regulatory authority of that name designated as a Stringent Regulatory Authority by the World Health Organization pursuant to the operation of the COVAX Facility;
“United Kingdom vaccine roll-out overseas” means the administration of vaccination against coronavirus to—
Crown servants, government contractors or other personnel posted or based overseas and their dependants under the scheme known as the Foreign, Commonwealth and Development Office staff COVID-19 vaccination programme; [F14or]
F15...
military or civilian personnel, government contractors and their dependants at a military posting overseas, including the British overseas territories, the Channel Islands and the Isle of Man, under the vaccination scheme provided or approved by the UK Defence Medical Services.
[F16“vaccine certificate”, in relation to a passenger (“P”), means a certificate in English, French or Spanish issued by the competent health authority of a relevant country, other than a European country listed in the table in paragraph (3) or the United States of America, which contains—
P’s full name;
P’s date of birth;
the name and manufacturer of the vaccine that P received;
the date that P received the dose of the vaccine or, as the case may be, each dose of the vaccine;
details of the identity of the issuer of the certificate or the country of vaccination or both.]
[F17(2A) The following countries and territories are approved third countries or territories for the purposes of this Part—
Albania
Armenia
[F18Cape Verde]
[F18El Salvador]
Faroe Islands
Israel
Morocco
North Macedonia
Panama
[F18Togo ]
Turkey
Ukraine.
(2B) The table referred to in the definition of “North American Certificate” in paragraph (2) is—
State | Certificate Name |
---|---|
California | Digital COVID-19 Vaccine Record |
New York | Excelsior Pass Plus |
Washington State | WA Verify] |
(3) The table referred to in paragraph (2) [F19except in the definition of “North American Certificate] is—
Relevant country | Regulator |
---|---|
A member State | European Medicines Agency |
Andorra | European Medicines Agency |
Iceland | European Medicines Agency |
Liechtenstein | European Medicines Agency |
Monaco | European Medicines Agency |
Norway | European Medicines Agency |
San Marino | European Medicines Agency |
The Vatican City State | European Medicines Agency |
Switzerland | Swissmedic |
The United States of America | United States Food and Drug Administration |
Australia | The Therapeutic Goods Administration |
Canada | Health Canada |
(4) The countries and territories referred to in the definitions of “relevant country” and “authorised vaccine” are—
[F20Albania]
[F21Algeria]
[F22Angola]
[F22Anguilla]
Antigua and Barbuda
[F22Argentina]
[F22Armenia]
[F22Azerbaijan]
[F20Bahamas]
Bahrain
[F20Bangladesh]
Barbados
[F23Belarus]
[F22Belize]
[F22Bermuda]
[F24Bhutan]
[F23Bolivia]
[F20Bosnia and Herzegovina]
[F22Botswana]
[F20Brazil]
[F22British Antarctic Territory]
[F22British Indian Ocean Territory]
[F22British Virgin Islands]
Brunei
[F22Cambodia]
[F24Cameroon]
[F22Cayman Islands]
[F20Chile]
[F21China]
[F20Colombia]
[F22Costa Rica]
[F24Côte d’Ivoire]
[F24Cyprus, northern]
[F23Democratic Republic of the Congo]
[F22Djibouti]
Dominica
[F23Dominican Republic]
[F23Ecuador]
[F20Egypt]
[F22Eswatini]
[F22Falkland Islands]
[F24Fiji]
[F20Georgia]
[F20Ghana]
[F22Gibraltar]
[F20Grenada]
[F21Guatemala]
[F22Guernsey]
[F22Guyana]
[F22Honduras]
[F20Hong Kong]
[F20India]
[F20Indonesia]
[F21Iran]
[F24Iraq]
[F22Isle of Man]
Israel
[F20Jamaica]
Japan
[F22Jersey]
[F20Jordan]
[F21Kazakhstan]
[F20Kenya]
[F20Kosovo]
Kuwait
[F21Kyrgyzstan]
[F23Laos]
[F22Lebanon]
[F22Lesotho]
[F24Liberia]
[F23Libya]
[F21Macao SAR]
[F22Madagascar]
[F23Malawi]
Malaysia
[F20Maldives]
[F24Mali]
[F24Mauritania]
[F22Mauritius]
[F21Mexico]
[F20Moldova]
[F22Mongolia]
[F20Montenegro]
[F22Montserrat]
[F20Morocco]
[F23Mozambique]
[F20Namibia]
[F22Nepal]
New Zealand
[F24Niger]
[F20Nigeria]
[F20North Macedonia]
[F22Occupied Palestinian Territories]
[F20Oman]
[F20Pakistan]
[F24Palau]
[F22Panama]
[F24Papua New Guinea]
[F24Paraguay]
[F22Peru]
[F20The Philippines]
[F22Pitcairn, Henderson, Ducie and Oeno Islands]
Qatar
[F22Rwanda]
[F22Saint Helena, Ascension and Tristan da Cunha]
[F23Samoa]
[F21Sao Tome and Principe]
Saudi Arabia
[F23Senegal]
[F20Serbia]
[F22Seychelles]
[F22Sierra Leone]
Singapore
[F24Solomon Islands]
[F20South Africa]
[F22South Georgia and the South Sandwich Islands]
South Korea
[F21South Sudan]
[F22The Sovereign Base Areas of Akrotiri and Dhekelia in the Island of Cyprus]
[F22Sri Lanka]
[F20St Kitts and Nevis]
[F20St Lucia]
[F20St Vincent and the Grenadines]
[F22Suriname]
Taiwan
[F22Tanzania]
[F20Thailand]
[F24The Gambia]
[F21Timor-Leste]
[F21Tonga]
[F22Trinidad and Tobago]
[F22Tunisia]
[F20Turkey]
[F21Turkmenistan]
[F22Turks and Caicos Islands]
[F22Uganda]
[F20Ukraine]
United Arab Emirates.
[F22Uruguay]
[F24Uzbekistan]
[F23Vanuatu]
[F20Vietnam]
[F23Zambia]
[F23Zimbabwe.]
[F25(5) Where a course of doses of an authorised vaccine has been administered to a person (“P”) by a person acting on behalf of the United Nations and authorised to administer the vaccination in that capacity, P is to be treated as if they have received those doses in a relevant country listed in paragraph (4), and any reference to doses received in a relevant country, or to the competent health authority of a relevant country in these Regulations is to be construed as including doses administered by a person acting on behalf of the United Nations.]]
Textual Amendments
F1Pt. 1B inserted (4.10.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 13) Regulations 2021 (S.I. 2021/1107), regs. 1(2), 6
F2Reg. 3A(1)(c) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(a) (with reg. 23)
F3Words in reg. 3A(2) inserted (1.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) Regulations 2021 (S.I. 2021/1210), regs. 1(2), 5(2)(a)(i) (with reg. 17(1))
F4Reg. 3A(2): closing bracket inserted (1.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) Regulations 2021 (S.I. 2021/1210), regs. 1(2), 5(2)(a)(ii) (with reg. 17(1))
F5Words in reg. 3A(2) substituted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(b)(i) (with reg. 23)
F6Words in reg. 3A(2)(c)(ii) substituted (10.1.2022 at 4:00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) Regulations 2022 (S.I. 2022/11), regs. 1(2)(b), 6(2)(a)
F7Words in reg. 3A(2)(c)(ii) substituted (10.1.2022 at 4:00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) Regulations 2022 (S.I. 2022/11), regs. 1(2)(b), 6(2)(b)
F8Words in reg. 3A(2) omitted (11.2.2022 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 2) Regulations 2022 (S.I. 2022/125), regs. 1(2), 6(2)(a) (with reg. 37(1)(2))
F9Words in reg. 3A(2) omitted (11.2.2022 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 2) Regulations 2022 (S.I. 2022/125), regs. 1(2), 6(2)(b) (with reg. 37(1)(2))
F10Word in reg. 3A(2) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(b)(ii)(aa) (with reg. 23)
F11Word in reg. 3A(2) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(b)(ii)(bb) (with reg. 23)
F12Words in reg. 3A(2) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(b)(iii) (with reg. 23)
F13Words in reg. 3A(2) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(b)(iv) (with reg. 23)
F14Word in reg. 3A(2) inserted (1.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) Regulations 2021 (S.I. 2021/1210), regs. 1(2), 5(2)(b)(i) (with reg. 17(1))
F15Words in reg. 3A(2) omitted (1.11.2021 at 4.00 a.m.) by virtue of The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) Regulations 2021 (S.I. 2021/1210), regs. 1(2), 5(2)(b)(ii) (with reg. 17(1))
F16Words in reg. 3A(2) inserted (1.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) Regulations 2021 (S.I. 2021/1210), regs. 1(2), 5(2)(c) (with reg. 17(1))
F17Reg. 3A(2A)(2B) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(c) (with reg. 23)
F18Words in reg. 3A(2A) inserted (11.2.2022 at 4.00 a.m. for entries "Cape Verde", "El Salvador" and "Togo, 28.2.2022 at 4.00 a.m. in so far as not already in force) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 2) Regulations 2022 (S.I. 2022/125), regs. 1(2)(b)(ii), 6(3) (with reg. 37(1)(2))
F19Words in reg. 3A(3) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(d) (with reg. 23)
F20Words in reg. 3A(4) inserted (11.10.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 14) Regulations 2021 (S.I. 2021/1130), regs. 1(3), 5(2) (with reg. 23(2))
F21Words in reg. 3A(4) inserted (11.2.2022 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 2) Regulations 2022 (S.I. 2022/125), regs. 1(2), 6(4)(a) (with reg. 37(1)(2))
F22Words in reg. 3A(4) inserted (1.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) Regulations 2021 (S.I. 2021/1210), regs. 1(2), 5(3) (with reg. 17(1)) (as amended by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 17) (Amendment) Regulations 2021 (S.I. 2021/1213), regs. 1(2), 2(2))
F23Words in reg. 3A(4) inserted (22.11.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021 (S.I. 2021/1289), regs. 1(2), 4(e) (with reg. 23)
F24Words in reg. 3A(4) inserted (10.1.2022 at 4:00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) Regulations 2022 (S.I. 2022/11), regs. 1(2)(b), 6(3)
F25Reg. 3A(5) inserted (11.10.2021 at 4.00 a.m.) by The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 14) Regulations 2021 (S.I. 2021/1130), regs. 1(3), 5(3) (with reg. 23(2))
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: